Drug Shortage Report for JAMP-TADALAFIL
Report ID | 34247 |
Drug Identification Number | 02451859 |
Brand name | JAMP-TADALAFIL |
Common or Proper name | Tadalafil |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-22 |
Estimated end date | |
Actual end date | 2018-02-12 |
Shortage status | Resolved |
Updated date | 2018-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-12-22 | English | Compare |
v2 | 2017-12-22 | French | Compare |
v3 | 2017-12-22 | English | Compare |
v4 | 2017-12-22 | French | Compare |
v5 | 2017-12-23 | English | Compare |
v6 | 2018-02-06 | English | Compare |
v7 | 2018-02-06 | French | Compare |
v8 | 2018-02-12 | English | Compare |
v9 | 2018-02-12 | French | Compare |
v10 | 2018-02-13 | English | Compare |
Showing 1 to 10 of 10